A case of ustekinumab-induced pustular psoriasis was treated with IL-17A inhibitor

We report a case of ustekinumab-induced pustular psoriasis treated with IL-17A inhibitor. A 51-year-old female presented with red plaques and scales for 20 years, with aggravation and pustules for over 10 days. The patient was previously diagnosed with plaque psoriasis, and poorly responded to syste...

Full description

Saved in:
Bibliographic Details
Main Authors: LIN Junjie, OU Min, LI Yang, SHE Xinyan, CAI Liting, GUAN Zepu, WANG Xiaohua
Format: Article
Language:zho
Published: editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology 2024-11-01
Series:Pifu-xingbing zhenliaoxue zazhi
Subjects:
Online Access:http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2024.11.009
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850120545792688128
author LIN Junjie
OU Min
LI Yang
SHE Xinyan
CAI Liting
GUAN Zepu
WANG Xiaohua
author_facet LIN Junjie
OU Min
LI Yang
SHE Xinyan
CAI Liting
GUAN Zepu
WANG Xiaohua
author_sort LIN Junjie
collection DOAJ
description We report a case of ustekinumab-induced pustular psoriasis treated with IL-17A inhibitor. A 51-year-old female presented with red plaques and scales for 20 years, with aggravation and pustules for over 10 days. The patient was previously diagnosed with plaque psoriasis, and poorly responded to systemic medications. After ruling out contraindications, the patient was subcutaneously given 45 mg of ustekinumab, resulting in clearance of the skin lesion. But erythema and scales with pustules appeared all over the body after the fourth treatment. Physical examination revealed scattered red plaques covered with white-silver scales, and Auspitz sign (+) on the head and face. The trunk and limbs were scattered with large erythematous patches and erythematous plaques, covered with various size of dense pustules, in a target-shape with a brown center. Some pustules merged to pus-lake. Pustules with erosive surface were scattered on the vulvar mucosa. Nails appeared thimble-like with nail plate thickening. Histopathology showed hyperkeratosis, parakeratosis, thinning or disappearance of granular layer, psoriasis-like epidermal hyperplasia, Munro and Kogoj microabscesses, papillary dermal edema, vascular dilation, and perivascular lymphocytic infiltration. Diagnosis was pustular psoriasis. After the treatment with topical corticosteroids and 160 mg of ixekizumab, the rashes subsided within 3 days. Afterwards, patient was treated with ixekizumab according to the manufacturer′s instruction, without the development of new lesion during 1-year follow-up.
format Article
id doaj-art-a9090ea03e694f13a2994e4f3f94aa67
institution OA Journals
issn 1674-8468
language zho
publishDate 2024-11-01
publisher editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology
record_format Article
series Pifu-xingbing zhenliaoxue zazhi
spelling doaj-art-a9090ea03e694f13a2994e4f3f94aa672025-08-20T02:35:19Zzhoeditoiral office of Journal of Diagnosis and Therapy on Dermato-venereologyPifu-xingbing zhenliaoxue zazhi1674-84682024-11-01311177878210.3969/j.issn.1674-8468.2024.11.009A case of ustekinumab-induced pustular psoriasis was treated with IL-17A inhibitorLIN Junjie0OU Min1LI Yang2SHE Xinyan3CAI Liting4GUAN Zepu5WANG Xiaohua6Dermatology Hospital, Southern Medical University, Guangzhou 510091, ChinaHuizhou Dermatology Hospital, Huizhou 516008, ChinaDermatology Hospital, Southern Medical University, Guangzhou 510091, ChinaDermatology Hospital, Southern Medical University, Guangzhou 510091, ChinaDermatology Hospital, Southern Medical University, Guangzhou 510091, ChinaDermatology Hospital, Southern Medical University, Guangzhou 510091, ChinaDermatology Hospital, Southern Medical University, Guangzhou 510091, ChinaWe report a case of ustekinumab-induced pustular psoriasis treated with IL-17A inhibitor. A 51-year-old female presented with red plaques and scales for 20 years, with aggravation and pustules for over 10 days. The patient was previously diagnosed with plaque psoriasis, and poorly responded to systemic medications. After ruling out contraindications, the patient was subcutaneously given 45 mg of ustekinumab, resulting in clearance of the skin lesion. But erythema and scales with pustules appeared all over the body after the fourth treatment. Physical examination revealed scattered red plaques covered with white-silver scales, and Auspitz sign (+) on the head and face. The trunk and limbs were scattered with large erythematous patches and erythematous plaques, covered with various size of dense pustules, in a target-shape with a brown center. Some pustules merged to pus-lake. Pustules with erosive surface were scattered on the vulvar mucosa. Nails appeared thimble-like with nail plate thickening. Histopathology showed hyperkeratosis, parakeratosis, thinning or disappearance of granular layer, psoriasis-like epidermal hyperplasia, Munro and Kogoj microabscesses, papillary dermal edema, vascular dilation, and perivascular lymphocytic infiltration. Diagnosis was pustular psoriasis. After the treatment with topical corticosteroids and 160 mg of ixekizumab, the rashes subsided within 3 days. Afterwards, patient was treated with ixekizumab according to the manufacturer′s instruction, without the development of new lesion during 1-year follow-up.http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2024.11.009pustular psoriasisdrug rashustekinumabil-12il-23ixekizumab
spellingShingle LIN Junjie
OU Min
LI Yang
SHE Xinyan
CAI Liting
GUAN Zepu
WANG Xiaohua
A case of ustekinumab-induced pustular psoriasis was treated with IL-17A inhibitor
Pifu-xingbing zhenliaoxue zazhi
pustular psoriasis
drug rash
ustekinumab
il-12
il-23
ixekizumab
title A case of ustekinumab-induced pustular psoriasis was treated with IL-17A inhibitor
title_full A case of ustekinumab-induced pustular psoriasis was treated with IL-17A inhibitor
title_fullStr A case of ustekinumab-induced pustular psoriasis was treated with IL-17A inhibitor
title_full_unstemmed A case of ustekinumab-induced pustular psoriasis was treated with IL-17A inhibitor
title_short A case of ustekinumab-induced pustular psoriasis was treated with IL-17A inhibitor
title_sort case of ustekinumab induced pustular psoriasis was treated with il 17a inhibitor
topic pustular psoriasis
drug rash
ustekinumab
il-12
il-23
ixekizumab
url http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2024.11.009
work_keys_str_mv AT linjunjie acaseofustekinumabinducedpustularpsoriasiswastreatedwithil17ainhibitor
AT oumin acaseofustekinumabinducedpustularpsoriasiswastreatedwithil17ainhibitor
AT liyang acaseofustekinumabinducedpustularpsoriasiswastreatedwithil17ainhibitor
AT shexinyan acaseofustekinumabinducedpustularpsoriasiswastreatedwithil17ainhibitor
AT cailiting acaseofustekinumabinducedpustularpsoriasiswastreatedwithil17ainhibitor
AT guanzepu acaseofustekinumabinducedpustularpsoriasiswastreatedwithil17ainhibitor
AT wangxiaohua acaseofustekinumabinducedpustularpsoriasiswastreatedwithil17ainhibitor
AT linjunjie caseofustekinumabinducedpustularpsoriasiswastreatedwithil17ainhibitor
AT oumin caseofustekinumabinducedpustularpsoriasiswastreatedwithil17ainhibitor
AT liyang caseofustekinumabinducedpustularpsoriasiswastreatedwithil17ainhibitor
AT shexinyan caseofustekinumabinducedpustularpsoriasiswastreatedwithil17ainhibitor
AT cailiting caseofustekinumabinducedpustularpsoriasiswastreatedwithil17ainhibitor
AT guanzepu caseofustekinumabinducedpustularpsoriasiswastreatedwithil17ainhibitor
AT wangxiaohua caseofustekinumabinducedpustularpsoriasiswastreatedwithil17ainhibitor